| ALL | acute lymphocytic leukemia | FL | follicular lymphoma |
| alt-NHEJ | alternative non-homologous end joining | MM | multiple myeloma |
| AML | acute myelocytic leukemia | MMR | mismatch repair |
| APE1 | AP endonuclease 1 | MOF | males-absent-on-the-first |
| ATM | ataxia-telangiectasia-mutated | MOF | KAT8, Lysine Acetyltransferase 8 |
| ATR | ataxia-telangiectasia and rad3 related | MORC2 | Microrchidia family CW-type zinc finger 2 |
| BER | base excision repair | MORF | MOZ-related factor |
| BET | bromodomain and extra terminal domain | MOZ | Monocytic leukemia zinc-finger protein |
| BRCA | BRCA1 DNA repair associated | MPG | Methylpurine DNA glycosylase |
| BRG | ATP-dependent helicase SMARCA4 | MSH2 | MutS homolog 2 |
| CBP | CREB-binding protein | mtDNA | mitochondrial DNA |
| CCAR2 | cell cycle and apoptosis regulator protein 2 | mtSSB | mitochondrial SSB |
| CETN2 | centrin 2 | MYH | MutY glycosylase homolog |
| c-NHEJ | canonical non-homologous end-joining factor | NEIL1 | Nei Like DNA Glycosylase 1 |
| CRL4 | CUL4-ring E3 ubiquitin ligase | NER | Nucleotide excision repair |
| CSA | Cockayne-syndrome A | Non-HL | non-Hodgkin Lymphoma |
| CTCL | cutaneous T-cell lymphoma | NSCLC | Non-small cell lung cancer |
| CtIP | CtBP-interacting protein | NTH1 | endonuclease III homolog |
| Cul4 | cullin protein 4 | OGG1 | 8-OxoG DNA glycosylase |
| DDB1 | DNA-binding protein 1 | PARP-1 | poly (ADP-ribose) polymerase-1 |
| DDB2 | DNA-binding protein 2 | PARPi | PARP-1 inhibitor |
| DDR | DNA damage response | PARylation | poly-ADP-ribosylation |
| DLBCL | diffuse large B-cell lymphoma | PCAF | p300/CBP-associated factor |
| DNA pol | DNA polymerase | PCNA | proliferating cell nuclear antigen |
| DNA-PK | DNA-dependent protein kinase | PTCL | peripheral T cell lymphoma |
| DNA-PKcs | DNA-dependent protein kinase catalytic subunit | PTM | post-translational modification |
| dRP | deoxyribose phosphate | RAD51 | recombinant DNA repair protein 51 |
| dNTP | deoxynucleotide triphosphate | RAD52 | Rad52 homolog |
| DSBs | Double strand breaks | RBX1 | RING box-domain protein |
| ER | estrogen receptor | RNAP II | RNA polymerase II |
| ESCO1 | establishment of sister chromatid cohesion n-acetyltransferase 1 | RNR | ribonucleotide reductase |
| EXO | exonuclease 1 | ROS | reactive oxygen species |
| FDA | Food and Drug Administration | RPA | replication protein A |
| FEN1 | flap structure-specific endonuclease 1 | SAHA | suberoylanilide hydroxamic acid |
| FL | follicular lymphoma | SFN | Sulforaphane |
| GCN5 | general control non-derepressible 5 | SIRT | Sirtuin |
| GGC-NE | global genome coupled-NER | SMUG1 | single-strand-selective monofunctional uracil glycosylase 1 |
| GNAT | Gcn5-related N-acetyltransferase | SSBs | single-stranded DNA binding proteins |
| HAT1 | lysine acetyltransferase 1 | SWI/SNF | switching/sucrose non-fermenting |
| HATs | lysine acetyltransferases | ATAT1 | α-tubulin N-acetyltransferase 1 |
| HBO1 | HAT bound to ORC1 | TC-NER | transcription coupled-NER |
| HDACI | HDAC inhibitor | TDG | thymine DNA glycosylase |
| HDACS | lysine deacetylases | Tip60 | Tat-interacting protein of 60 kDa |
| HER2 | human epidermal growth factor receptor-2 | TyrRS | tyrosyl-tRNA synthetase |
| HL | Hodgkin lymphoma | UNG | Uracil DNA glycosylase |
| HR | homologous recombination | WEE1 | Wee1-like protein kinase |
| HR23B | Rad23 homolog B | XLF | XRCC4-like factor |
| IR | ionizing radiation | XPA | Xeroderma pigmentosum group A |
| LATS1 | large tumor suppressor homolog 1 | XPB | Xeroderma pigmentosum complementation group B |
| LIG3 | Ligases | XPC | Xeroderma pigmentosum complementation group C |
| LIG4 | DNA ligase IV | XPD | Xeroderma pigmentosum complementary group D |
| MBD4 | methyl CpG binding domain protein 4 | XPG | Xeroderma pigmentosum complementation group G |
| MDR | multidrug resistance | XRCC3 | X-ray repair cross complementing 3 |
| MDS | myelodysplastic syndrome | XRCC4 | X-ray repair cross complementing 4 |